الولايات المتحدة · مجلات اقتصادية · Institutional Investor

Biopharma’s Sickly September

نشره Institutional Investor · الولايات المتحدة منذ 5 ي

September was a rough month for prominent biopharma and life sciences hedge funds.Many lost money, some by double-digit percentage rates. As a result, quite a few funds are up…

اقرأ المقال كاملًا على Institutional Investor سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.institutionalinvestor.com)

يستحق القراءة أيضًا

Inc.

Think Being a Night Owl Is Just a Sleep Preference? Researchers Link It to a Depression Subtype

Markets Insider (Business Insider)

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO

Kiplinger

Biopharma’s Sickly September

مشاركة

يستحق القراءة أيضًا

Think Being a Night Owl Is Just a Sleep Preference? Researchers Link It to a Depression Subtype

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fervo Energy Company Investors to Inquire About Securities Class Action Investigation - FRVO

Can a Roth Conversion Wait if You're 5-10 Years From Retiring?

Look up tonight: October’s full moon is for hunters

Millennials are having their midlife career crisis

Carson Hocevar Is Telling NASCAR Fans To Vote For Somebody Else